No Data
No Data
Retail Investors Among Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Largest Stockholders and Were Hit After Last Week's 4.4% Price Drop
Anke Biotech: Report for the third quarter of 2024
Anhui Anke Biotechnology (300009.SZ) released its performance for the first three quarters, with a net income of 0.59 billion yuan, a year-on-year decrease of 9.89%.
Anhui Anke Biotechnology (300009.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Anhui Anke Biotechnology Gets API Approval for Platelet Inhibitor
Anhui Anke Biotechnology Plans to Invest 40 Million Yuan in Cell Therapy JV
Chinese Drug Regulator Accepts Anke Biotechnology's Supplementary Application for Eye Drops
No Data
No Data